| abstract |
The human milk oligosaccharide mixture comprises or consists essentially of a) LNTri II, LNT, pLNH II and optionally lactose, or b) LNTri II, LNnT, pLNnH and optionally lactose, which can be used for prophylaxis Or to treat viral or bacterial intestinal and respiratory infections, and to modulate the human gastrointestinal microbiota to increase bifidobacteria abundance. Methods of preparation of the mixtures and methods of crystallizing LNnT and LNT are also described. |